(Asian News Hub) – The Health Ministry addressing the media on Tuesday confirmed that Covid is spreading faster than ever before while terming the situation in Chhattisgarh to be a cause of concern.
A day after India’s daily COVID cases crossed one lakh for the first time since the pandemic, the Health Ministry officials said that Chhattisgarh’s Durg was among the top 10 districts with high active COVID cases. Other districts s included seven in Maharashtra, including Mumbai and Pune, and one in Karnataka.
The intensity of the COVID-19 pandemic has increased in India and it is spreading faster than last time, they added.
According to Health Ministry, Maharashtra, Punjab and Chhattisgarh remain states of maximum concern on account of high daily COVID-19 cases, deaths.
“The intensity of the pandemic has increased and it is spreading faster than last time. In some states, it (the condition) is worse than others but the upswing (in cases) can be observed across the country,” he said.
“People’s participation is vital to control the second wave. The next four weeks are going to very critical. The entire country has to come together and make efforts to fight the pandemic.”
He said the number of coronavirus cases is increasing and along with that mortality is also on the rise.
“Still, in terms of the population size and in terms of deaths per million we are doing well and the pandemic is in control.”
Detailing the COVID-19 situation in India, Union Health Secretary Rajesh Bhushan said Chhattisgarh’s Durg is among the top 10 districts with high active COVID cases.
“Among these 10 districts, seven are in Maharashtra and one in Karnataka. Delhi, counted as one district, is also in the list.”
The 10 districts with the highest number of new cases are Pune, Mumbai, Thane, Nagpur, Nashik, Bengaluru Urban, Aurangabad, Ahmednagar, Delhi and Durg, he said.
Bhushan further said that Maharashtra, Punjab and Chhattisgarh still remain states of maximum concern.
“Given their population, the number of deaths being reported by Punjab and Chhatisgarh is a cause of extreme concern,” he said.
The Centre has constituted 50 high-level multi-disciplinary public health teams and deployed them to districts reporting a surge in cases and mortality in Maharashtra, Chhattisgarh and Punjab, the Union health secretary said.
These teams were being deployed in 30 districts of Maharashtra, 11 of Chhattisgarh and nine of Punjab.
Maharashtra, Gujarat and West Bengal were among the states that administered the maximum number of COVID vaccine doses, Bhushan said and emphasised that the immunisation drive has to be ramped up in a scientific manner.
“Chhattisgarh is a cause of concern for us. Despite being a small state, it reports 6% of total COVID cases and 3% of total deaths in the country. The condition of Chhattisgarh has deteriorated in the second wave of infections,” said Union Health Secretary Rajesh Bhushan.
Stressing the need for RT-PCR tests, the Health Secretary said we have asked state governments to increase the percentage of RT-PCR tests, which had been falling in Maharashtra in the last few weeks.
Only 60% of total tests were done using the RT-PCR method in Maharashtra last week. We suggest states to take it to 70% or above, he explained.
Maharashtra, Gujarat and West Bengal were among states that administered the maximum number of COVID vaccine doses, it was noted.
In India, 96,982 daily cases have been reported in a span of 24 hours, while the death toll increased to 1,65,547 with 446 daily new fatalities, the data updated at 8 am showed.
(With agencies inputs)
Center issues guidelines on COVID-19 in children
Most drugs for treating adults not recommended for kids
(Asian News Hub) – In anticipation of likely intermittent surges in the number of COVID-19 cases, the government has come out with guidelines for operationalising Covid-care services for children.
Drugs such as ivermectin, hydroxychloroquine, favipiravir and antibiotics like doxycycline and azithromycin prescribed for adult COVID-19 patients have not been recommended for treating children, according to a government guideline issued on Wednesday.
The recommendations include augmenting existing Covid care facilities to provide care to children with acute coronavirus infection.
According to it, once vaccines are approved for children, those with comorbid conditions having more severe manifestations of COVID-19 and poorer outcomes should be a priority group for immunisation.
About the treatment of children, the guidelines by the Union Health Ministry said most drugs used in adults such as ivermectin, hydroxychloroquine, favipiravir and antibiotics such as doxycycline or azithromycin have not been tested on children for prevention or treatment of Covid infection among them. “Therefore, these are not recommended in children.”
The guidelines stated it is anticipated that there may be intermittent surges in the number of coronavirus cases.
“A combined effort from the private and public sector is needed to handle any surge (in cases) in the future after the withdrawal of the lockdown, school reopening or as a third wave over the next three to four months. The basic principles of equity and dignity of care should be followed,” it said.
The guidelines said estimates for additional bed capacity for pediatric care may be calculated based on peak daily cases in different districts during the second wave of the COVID-19 infections.
From this, projections for pediatric cases and the number of admissions required can be derived, it said.
“It is desirable to augment the existing Covid-care facilities to provide care to children with acute Covid. This will need additional pediatric-specific equipment, infrastructure and pediatric formulations.
“Also, an adequate number of trained manpower — both doctors and nurses — should be provided. The health authorities should initiate capacity building programmes for appropriate pediatric care. In standalone paediatric hospitals, separate arrangements, for example, separate beds for paediatric Covid care need to be set up,” the guidelines said.It is desirable to designate specific areas in the Covid facilities for pediatric care and parents should be allowed to accompany the child there.
“For children with Multisystem Inflammatory Syndrome who test negative for acute Covid, care has to be provided by the existing pediatric facilities. These facilities also need augmentation especially HDU and ICU services,” it said.
The document provides guidance about additional requirements for infrastructure, equipment and manpower.
Noting that a majority of children have asymptomatic or mild illness and can be managed at home by parents, it said treatment for symptomatic patients include paracetamol for fever and monitoring conditions such as measuring respiratory rates, difficulty in respiration, oral intake and oxygen saturation.
“In a community setting, ASHA and MPW should be involved for management of children at home and also monitor to assess the need for referral and admission,” the guidelines said.
The document stressed on imparting training to community health workers for picking up the red flag signs. Also, all stakeholders, including the community, should be educated by the information education communication.
For improving the quality of care and for capacity building, the guidelines recommended hand-holding of district hospitals and other facilities by medical colleges.
“A few centres may be designated as regional centres of excellence for Covid care and research. These centres can provide leadership in clinical management and training.
Telemedicine could be harnessed for reaching out to a large number of facilities,” it said.
To ensure data collection at all levels and transmission from community to higher centres, the document recommended that a national registry be launched for pediatric Covid.
“There is a need to encourage and facilitate research in the area of pediatric Covid and this could cover various aspects of management.
Similarly, issues of optimal treatment for MIS-C need to be addressed by clinical trials, such as comparison of low dose with high doses steroids, comparison of steroids with IVIG and others,” it added.
The guidelines said that based on sero-surveillance reports, COVID-19 infection in children above 10 years of age occurs in a similar frequency to that of adults, even though among the confirmed cases less than 12 per cent are individuals less than 20 years of age.
“Children have less severe disease than adults. In the majority, the infection is asymptomatic or mildly symptomatic. It is uncommon to have moderate to severe Covid among healthy children,” it noted.
India reports first case of green fungus infection
(Asian News hub) – After black and white fungus, a case of green fungus is reported in Indore district of Madhya Pradesh with a 34-year-old patient admitted to a private medical college on Tuesday.
It is the first such case of green fungus in the state, said doctors.
The patient, a businessman, was undergoing treatment at Sri Aurobindo Institute of Medical Sciences (SAIMS) for the last two months firstly for Covid-19 and then fungal infection.
SAIMS respiratory medicine HoD Dr Ravi Dosi said, “The patient was found suffering from green fungus (Aspergillus fungus) infection in lungs.”The patient was not responding well to the treatment. As his lungs has 90% infection, he was airlifted to Hinduja Hospital in Mumbai, said Dr Dosi. Dr Dosi said, “It is the first case of green fungus in Madhya Pradesh.
But about the country I am not sure.” The reports, however, suggested that in different parts of the country only cases of black, white and yellow fungus cases were reported so far. However, experts differ on this colour coding of the Aspergillus fungus. Dr VP Pandey, HoD medicine department, MGM said, “There is no colour coding of fungal infection. The only thing is that it is aspergillus fungus and mucormycosis.”
“It is not that the fungal infection gives colour shades in the body. Its name is because the colour appears during its culture in the lab while testing it,” said Dr Dosi. Dr Anita Mutha, HoD microbiology department MGM, said, “Fungus show colour in their culture. There are black, yellow, green and white fungus, but these are all specimens of mucormycosis, cinderella and aspergillus.”
Mucormycosis gives black colour, while cinderella gives white and aspergillus gives green and yellow colour in different species, said Dr Mutha explaining about the fungal infection.
Lioness dies after testing positive for COVID-19 in Chennai
(Asian News Hub) – A nine-year old Asiatic lion has died from the coronavirus in a state-run zoo on the outskirts of the south Indian city of Chennai, the zoo said on Friday.
There have been various coronavirus cases in animals, including two white white tiger cubs thought to have died of COVID-19 in neighbouring Pakistan and lions also testing positive in Spain and two other cities of India.
“A 9-year old lioness Neela succumbed to the disease on the evening of 3rd June,” the Arignar Anna zoological park said of the latest incident.
The outbreak was first observed on Thursday, with most of the lions asymptomatic, it said. They were quarantined and given antibiotics.
“Samples of tigers and other large mammals are being sent for testing,” the zoo’s statement added.
Cop shot dead at Saidapora Eidgah
Woman injured in hit-and-run accident near Noora Hospital Sgr
World Bank rejects El Salvador’s request to help implement bitcoin as legal tender
- State5 days ago
4 including 2 civilians, 2 cops killed in Sopore militant attack
- Middle East5 days ago
Saudi Arabia says Hajj to be limited to 60,000 in kingdom
- International5 days ago
South Africa confirms third wave as COVID-19 cases continue to Soar
- Medical Science5 days ago
New Coronavirus found in bats in china, Scientists worried
- State4 days ago
Active Al-Badr militant found dead in Soura, Sgr
- Business5 days ago
Gondola service resumes partially in Gulmarg
- State2 days ago
Gunfight rages in Srinagar
- Medical Science3 days ago
COVID19: Single dose of vaccine sufficient for those already infected; Study